Additionally, CLL cases with trisomy 12 exhibited higher levels of MYC target gene activation than those without trisomy 12, regardless of IGHV mutational status (p < 0.001) (Figure 1b; Supplementary Figure S2c). The gene discussed is MYC; the disease is B-cell chronic lymphocytic leukemia.